Pavel Skalický

546 total citations
48 papers, 298 citations indexed

About

Pavel Skalický is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pavel Skalický has authored 48 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 24 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pavel Skalický's work include Pancreatic and Hepatic Oncology Research (23 papers), Pancreatitis Pathology and Treatment (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Pavel Skalický is often cited by papers focused on Pancreatic and Hepatic Oncology Research (23 papers), Pancreatitis Pathology and Treatment (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Pavel Skalický collaborates with scholars based in Czechia, Germany and Serbia. Pavel Skalický's co-authors include Martin Loveček, Č Neoral, Jiří Ehrmann, R Havlík, Bohuslav Melichar, Radek Vrba, Beatrice Mohelníková-Duchoňová, Filip Čečka, Vladislav Raclavský and Eva Čermáková and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and World Journal of Gastroenterology.

In The Last Decade

Pavel Skalický

44 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavel Skalický Czechia 10 168 121 96 78 74 48 298
Gianluca Businello Italy 10 116 0.7× 81 0.7× 86 0.9× 60 0.8× 50 0.7× 22 264
Tsuyoshi Notake Japan 11 162 1.0× 189 1.6× 86 0.9× 45 0.6× 59 0.8× 73 381
Chao‐Wen Hsu Taiwan 11 122 0.7× 134 1.1× 89 0.9× 50 0.6× 35 0.5× 30 288
Yingjian Song China 10 192 1.1× 46 0.4× 133 1.4× 102 1.3× 99 1.3× 16 373
Naveena A. N. Kumar India 9 117 0.7× 111 0.9× 68 0.7× 64 0.8× 42 0.6× 50 277
Abdullah Zorluoğlu Türkiye 12 120 0.7× 163 1.3× 79 0.8× 104 1.3× 35 0.5× 29 390
Chia‐Lin Chou Taiwan 11 117 0.7× 70 0.6× 65 0.7× 104 1.3× 47 0.6× 39 311
Tomoyuki Minami Japan 12 195 1.2× 191 1.6× 100 1.0× 65 0.8× 43 0.6× 31 343
Satoshi Itano Japan 12 94 0.6× 160 1.3× 89 0.9× 40 0.5× 44 0.6× 52 433
Tomonari Shimagaki Japan 13 120 0.7× 107 0.9× 115 1.2× 112 1.4× 142 1.9× 47 467

Countries citing papers authored by Pavel Skalický

Since Specialization
Citations

This map shows the geographic impact of Pavel Skalický's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Skalický with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Skalický more than expected).

Fields of papers citing papers by Pavel Skalický

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel Skalický. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Skalický. The network helps show where Pavel Skalický may publish in the future.

Co-authorship network of co-authors of Pavel Skalický

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Skalický. A scholar is included among the top collaborators of Pavel Skalický based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Skalický. Pavel Skalický is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srovnal, Josef, Tomáš Gabrhelík, Martin Loveček, et al.. (2023). Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery. Cancers. 15(16). 4038–4038. 1 indexed citations
2.
Pavlík, Tomáš, et al.. (2023). Major iatrogenic bile duct injury during elective cholecystectomy: a Czech population register-based study. Langenbeck s Archives of Surgery. 408(1). 154–154. 2 indexed citations
3.
Falt, Přemysl, Jana Zapletalová, Petr Vaněk, et al.. (2023). Fluorescence In Situ Hybridization in Primary Diagnosis of Biliary Strictures: A Single-Center Prospective Interventional Study. Biomedicines. 11(3). 755–755. 3 indexed citations
4.
Waldauf, Petr, Peter Baláž, Martin Loveček, et al.. (2022). Silver-Based Dressings in the Prevention of the Incisional Surgical Site Infection: A Prospective Multicenter Observational Controlled Trial. Surgical Infections. 23(7). 682–690. 5 indexed citations
5.
Skalický, Pavel, et al.. (2021). Cyclomodulins and Hemolysis in E. coli as Potential Low-Cost Non-Invasive Biomarkers for Colorectal Cancer Screening. Life. 11(11). 1165–1165. 4 indexed citations
6.
Skalický, Pavel, et al.. (2021). The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma. Biomedical Papers. 166(4). 386–392. 3 indexed citations
7.
Skalický, Pavel, et al.. (2020). Candida albicans culture from a rectal swab can be associated with newly diagnosed colorectal cancer. Folia Microbiologica. 65(6). 989–994. 16 indexed citations
8.
Loveček, Martin, Markéta Janatová, Pavel Skalický, et al.. (2019). Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations. Cancer Management and Research. Volume 11. 599–609. 4 indexed citations
9.
Loveček, Martin, et al.. (2019). Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study. World Journal of Surgical Oncology. 17(1). 182–182. 9 indexed citations
10.
11.
Loveček, Martin, Pavel Skalický, Mininder S. Kocher, et al.. (2017). [Postpancreatectomy haemorrhage (PPH), prevalence, diagnosis and management].. PubMed. 95(9). 350–357. 7 indexed citations
12.
Skalický, Pavel, et al.. (2017). Are we any closer to screening for colorectal cancer using microbial markers?A critical review. Biomedical Papers. 161(4). 333–338. 7 indexed citations
13.
Loveček, Martin, et al.. (2016). Emergency surgical treatment of complicated acute pancreatitis after kidney transplantation with acute rejection: Case report and literature review. Annals of Medicine and Surgery. 8. 14–17. 2 indexed citations
14.
Loveček, Martin, Pavel Skalický, Č Neoral, et al.. (2015). [Surgical therapy of pancreatic cancer - 5 years survival].. PubMed. 94(11). 470–6. 2 indexed citations
16.
Srovnal, Josef, Pavel Skalický, Jana Vrbková, et al.. (2015). [Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using RT - PCR method].. PubMed. 94(11). 464–9; discussion 469. 6 indexed citations
17.
Čečka, Filip, et al.. (2014). [The role of drains in pancreatic surgery].. PubMed. 93(9). 450–5. 1 indexed citations
18.
Srovnal, Josef, Pavel Skalický, Z Chudáček, et al.. (2012). [Biomarkers in the detection of minimal systemic dissemination in lung cancer patients].. PubMed. 91(4). 209–15. 3 indexed citations
19.
Skalický, Pavel, et al.. (2005). [The intraabdominally located mesh in the laparotomy management of major hernias].. PubMed. 84(6). 310–3. 1 indexed citations
20.
Skalický, Pavel, et al.. (2004). Oncologic markers in patients with colorectal cancer after a complex therapy.. PubMed. 105(10-11). 389–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026